Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of ...

Perplexity is raising new investment that would value the search startup at $9 billion, a source familiar with the matter ...

1 Day IVP -0.85% DJIA 0.65% Russell 2K 1.63% Health Care/Life Sciences -0.41% ...

Perplexity is raising new investment that would value the search startup at $9 billion, a source familiar with the matter ...

An intravenous (IV) fluid shortage in the wake of Hurricane Helene is continuing after a major North Carolina factory was ...

Baxter, which makes around 60% of the IV solutions used in the US daily, announced that it has restarted its ...

(Nasdaq: GRCE) formerly Acasti Pharma Inc. (Grace Therapeutics or the Company), a late-stage, biopharma company advancing GTx-104, a clinical-stage, novel, injectable formulation of nimodipine being ...

The global sales of central venous catheters (CVC) are estimated to be valued at USD 2,861.0 million in 2024 and are expected ...

The AI-powered search company is set to raise $500 million, according to people familiar with the matter. The venture firm Institutional Venture Partners, which also holds a board seat in the ...

has granted Fast Track designation to Intravenous (IV) Choline Chloride, the Company’s investigational IV phospholipid substrate replacement therapy, as a source of choline for adult and ...

Allakos shifted focus to AK006 in 2024 after lirentelimab's failure in phase 2 trials for atopic dermatitis and CSU. Read why ...